Supply and Rights to D-MNA Sample Clauses

Supply and Rights to D-MNA. SPONSOR shall supply to the Principal Investigator, at SPONSOR's expense, the D-MNA. The INSTITUTION and the Principal Investigator shall handle the D-MNA in accordance with the Protocol and FDA regulations. The D-MNA is and remains the sole and exclusive property of SPONSOR. SPONSOR does not grant INSTITUTION and Principal Investigator any express or implied intellectual property rights in the D-MNA or in any methods of making or using the D-MNA. INSTITUTION on behalf of itself, personnel and Principal Investigator agree that the D-MNA shall only be used in connection with the Clinical Trial in accordance with the Protocol and any other use is a material breach of this Agreement. Any invention conceived related to the D-MNA in the course of activities that are in breach of this Agreement, and all intellectual property rights therein, shall be solely and exclusively owned by SPONSOR, and INSTITUTION shall reasonably execute and deliver any documents of assignment or conveyance to effectuate the ownership rights of SPONSOR in such invention and related intellectual property rights at Sponsor's expense. The Sponsor acknowledges that the Institution has a human research protection program ("HRPP") established in accordance with the principles and standards of the Association for the Accreditation of Human Research Protection Programs ("AAHRPP") that is applicable to clinical research studies and clinical trials, including the Research. In furtherance of the Institution's HRPP, the Sponsor affirms that the manufacture and formulation of the Product meets all applicable laws, regulations and rules, including manufacture in accordance with "Good Manufacturing Practices". Before the Research begins, the Sponsor will provide the Principal Investigator with an investigator brochure describing all known contraindications, warnings, precautions and adverse reactions associated with the administration of Product. If such information is revised while the Research is in progress, Sponsor will timely provide the latest revision to the Principal Investigator. Sponsor will report to the Institution promptly (no more than thirty (30) days) any urgent data safety and monitoring reports, e.g., any finding, event, or information, including any information generated from a monitoring visit, that could affect the safety of subjects or their willingness to continue participating in the Research, influence the conduct of the Research, or affect the IRB's approval to continue the R...
Sample 1
AutoNDA by SimpleDocs

Related to Supply and Rights to D-MNA

  • Definitions For purposes of this Agreement:

  • Miscellaneous The Vendor acknowledges and agrees that continued participation in TIPS is subject to TIPS sole discretion and that any Vendor may be removed from the participation in the Program at any time with or without cause. Nothing in the Agreement or in any other communication between TIPS and the Vendor may be construed as a guarantee that TIPS or TIPS Members will submit any orders at any time. TIPS reserves the right to request additional proposals for items or services already on Agreement at any time.

  • WHEREAS the Company desires the Warrant Agent to act on behalf of the Company, and the Warrant Agent is willing to so act, in connection with the issuance, registration, transfer, exchange, redemption and exercise of the Warrants; and

  • Confidentiality (a) Subject to Section 7.15(c), during the Term and for a period of three

  • NOW, THEREFORE the parties hereto agree as follows:

  • Indemnification In the event any Registrable Securities are included in a Registration Statement under this Agreement:

  • Entire Agreement This Agreement constitutes the entire agreement between the parties hereto with respect to the subject matter contained in this Agreement and supersedes all prior agreements, understandings and negotiations between the parties.

  • Notices Any notice, request or other document required or permitted to be given or delivered to the Holder by the Company shall be delivered in accordance with the notice provisions of the Purchase Agreement.

  • Termination This Agreement may be terminated at any time prior to the Closing:

  • Severability Any provision of this Agreement that is prohibited or unenforceable in any jurisdiction shall, as to such jurisdiction, be ineffective to the extent of such prohibition or unenforceability without invalidating the remaining provisions hereof, and any such prohibition or unenforceability in any jurisdiction shall not invalidate or render unenforceable such provision in any other jurisdiction.

Time is Money Join Law Insider Premium to draft better contracts faster.